Suchergebnisse - "Folschweiller, Nicolas"

PubPharm (15)

1

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue

enthalten in: The American journal of tropical medicine and hygiene | 2023

von Sáez-Llorens, X. | Biswal, S. | Borja-Tabora, C. | +7

2

A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country

enthalten in: Vaccine | 2023

von Tricou, V. | Eyre, S. | Ramjee, M. | +9

3

Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted : a phase 1-2 randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Folschweiller, N. | Vanden Abeele, C. | Chu, L. | +17

CommentIn: Lancet Infect Dis. 2022 Jul;22(7):926-928. - PMID 35461523

4

Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections : Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study

enthalten in: The Journal of infectious diseases | 2021

von Tota, J. | Struyf, F. | Hildesheim, A. | +15

5

Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine : Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials

enthalten in: Journal of the National Cancer Institute | 2020

von Tota, J. | Struyf, F. | Sampson, J. | +15

6

Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

enthalten in: Journal of viral hepatitis | 2019

von Van Damme, P. | Dionne, M. | Leroux-Roels, G. | +5

7

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

enthalten in: The Journal of infectious diseases | 2019

von Folschweiller, N. | Behre, U. | Dionne, M. | +16

8

A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

enthalten in: Human vaccines & immunotherapeutics | 2019

von Schwarz, T. | Huang, L. | Valencia, A. | +9

9

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years : A Randomized Trial

enthalten in: The Journal of infectious diseases | 2017

von Huang, L. | Puthanakit, T. | Cheng-Hsun, C. | +22

CommentIn: J Infect Dis. 2017 Sep 15;216(6):783-785. - PMID 28934440

10

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine

enthalten in: Human vaccines & immunotherapeutics | 2017

von Van Damme, P. | Leroux-Roels, G. | Suryakiran, P. | +2